pd 98059 and plx4032

pd 98059 has been researched along with plx4032 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hawley, T; Huang, L; Liu, J; Merlino, G; Qin, Y; Seo, C; Yu, Y; Zuo, Q	1

Other Studies

1 other study(ies) available for pd 98059 and plx4032

Article	Year
AXL/AKT axis mediated-resistance to BRAF inhibitor depends on PTEN status in melanoma. Oncogene, 2018, Volume: 37, Issue:24 Topics: Animals; Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Drug Resistance, Neoplasm; Flavonoids; Humans; Male; Melanoma; Mice; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Receptor Protein-Tyrosine Kinases; Vemurafenib; Xenograft Model Antitumor Assays	2018

Article

Year

AXL/AKT axis mediated-resistance to BRAF inhibitor depends on PTEN status in melanoma.

Oncogene, 2018, Volume: 37, Issue:24

Topics: Animals; Antineoplastic Agents; Axl Receptor Tyrosine Kinase; Drug Resistance, Neoplasm; Flavonoids; Humans; Male; Melanoma; Mice; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Receptor Protein-Tyrosine Kinases; Vemurafenib; Xenograft Model Antitumor Assays

2018